Qsymia 11.25/69 (phentermine / topiramate) 24 HR Extended Release Oral Capsule
- RxCUI
- 1313061
- RxNorm name
- Qsymia 11.25/69 (phentermine / topiramate) 24 HR Extended Release Oral Capsule
- Display name
- Qsymia 11.25/69 (phentermine / topiramate) 24 HR Extended Release Oral Capsule
- Full name
- Qsymia 11.25/69 (phentermine / topiramate) 24 HR Extended Release Oral Capsule
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:55
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Qsymia | PHENTERMINE AND TOPIRAMATE | Vivus LLC | 40dd5602-53da-45ac-bb4b-15789aba40f9 | 2026-04-22 | Warnings, Adverse reactions | 1313061 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 40dd5602-53da-45ac-bb4b-15789aba40f9 | Qsymia 11.25/69 (phentermine / topiramate) 24 HR Extended Release Oral Capsule | SY | 42 | These highlights do not include all the information needed to use QSYMIA ® safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 2012 | 20260422 |
| 40dd5602-53da-45ac-bb4b-15789aba40f9 | Qsymia 11.25/69 (phentermine 11.25 MG / topiramate 69 MG) 24 HR Extended Release Oral Capsule | SY | 42 | These highlights do not include all the information needed to use QSYMIA ® safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 2012 | 20260422 |
| 40dd5602-53da-45ac-bb4b-15789aba40f9 | Qsymia 11.25/69 (phentermine (as hydrochloride) / topiramate) 24 HR Extended Release Oral Capsule | SY | 42 | These highlights do not include all the information needed to use QSYMIA ® safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 2012 | 20260422 |
| 40dd5602-53da-45ac-bb4b-15789aba40f9 | Qsymia 11.25/69 24 HR Extended Release Oral Capsule | SY | 42 | These highlights do not include all the information needed to use QSYMIA ® safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 2012 | 20260422 |
| 40dd5602-53da-45ac-bb4b-15789aba40f9 | Qsymia 11.25 MG / 69 MG 24HR Extended Release Oral Capsule | PSN | 42 | These highlights do not include all the information needed to use QSYMIA ® safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 2012 | 20260422 |
| 40dd5602-53da-45ac-bb4b-15789aba40f9 | 24 HR phentermine 11.25 MG / topiramate 69 MG Extended Release Oral Capsule [Qsymia] | SBD | 42 | These highlights do not include all the information needed to use QSYMIA ® safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 2012 | 20260422 |